These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

704 related items for PubMed ID: 31397685

  • 1. Multicenter Validation Study of a Diagnostic Algorithm to Detect NASH and Fibrosis in NAFLD Patients With Low NAFLD Fibrosis Score or Liver Stiffness.
    Liebig S, Stoeckmann N, Geier A, Rau M, Schattenberg JM, Bahr MJ, Manns MP, Jaeckel E, Schulze-Osthoff K, Bantel H.
    Clin Transl Gastroenterol; 2019 Aug; 10(8):e00066. PubMed ID: 31397685
    [Abstract] [Full Text] [Related]

  • 2. Serum cytokeratin-18 fragment levels as noninvasive marker of nonalcoholic steatohepatitis in the chilean population.
    Arab JP, Hernández-Rocha C, Morales C, Vargas JI, Solís N, Pizarro M, Robles C, Sandoval D, Ponthus S, Benítez C, Barrera F, Soza A, Riquelme A, Arrese M.
    Gastroenterol Hepatol; 2017 Aug; 40(6):388-394. PubMed ID: 28359548
    [Abstract] [Full Text] [Related]

  • 3. Measurements of serum procollagen-III peptide and M30 do not improve the diagnostic accuracy of transient elastography for the detection of hepatic fibrosis in patients with nonalcoholic fatty liver disease.
    Ergelen R, Akyuz U, Aydin Y, Eren F, Yilmaz Y.
    Eur J Gastroenterol Hepatol; 2015 Jun; 27(6):667-71. PubMed ID: 25923941
    [Abstract] [Full Text] [Related]

  • 4. Poor Inter-test Reliability Between CK18 Kits as a Biomarker of NASH.
    Pimentel CF, Jiang ZG, Otsubo T, Feldbrügge L, Challies TL, Nasser I, Robson S, Afdhal N, Lai M.
    Dig Dis Sci; 2016 Mar; 61(3):905-12. PubMed ID: 26462489
    [Abstract] [Full Text] [Related]

  • 5. A biomarker panel for non-alcoholic steatohepatitis (NASH) and NASH-related fibrosis.
    Younossi ZM, Page S, Rafiq N, Birerdinc A, Stepanova M, Hossain N, Afendy A, Younoszai Z, Goodman Z, Baranova A.
    Obes Surg; 2011 Apr; 21(4):431-9. PubMed ID: 20532833
    [Abstract] [Full Text] [Related]

  • 6. Diagnosis and Evaluation of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis, Including Noninvasive Biomarkers and Transient Elastography.
    Tsai E, Lee TP.
    Clin Liver Dis; 2018 Feb; 22(1):73-92. PubMed ID: 29128062
    [Abstract] [Full Text] [Related]

  • 7. Usefulness of the index of NASH - ION for the diagnosis of steatohepatitis in patients with non-alcoholic fatty liver: An external validation study.
    Younes R, Rosso C, Petta S, Cucco M, Marietti M, Caviglia GP, Ciancio A, Abate ML, Cammà C, Smedile A, Craxì A, Saracco GM, Bugianesi E.
    Liver Int; 2018 Apr; 38(4):715-723. PubMed ID: 29028281
    [Abstract] [Full Text] [Related]

  • 8. Nonalcoholic fatty liver disease: biomarkers as diagnostic tools for liver damage assessment in adult patients from Argentina.
    Valva P, Rios D, Casciato P, Gadano A, Galdame O, Mullen E, Bertot G, de Matteo E, Preciado MV.
    Eur J Gastroenterol Hepatol; 2018 Jun; 30(6):637-644. PubMed ID: 29384795
    [Abstract] [Full Text] [Related]

  • 9. Evaluation and comparison of six noninvasive tests for prediction of significant or advanced fibrosis in nonalcoholic fatty liver disease.
    Staufer K, Halilbasic E, Spindelboeck W, Eilenberg M, Prager G, Stadlbauer V, Posch A, Munda P, Marculescu R, Obermayer-Pietsch B, Stift J, Lackner C, Trauner M, Stauber RE.
    United European Gastroenterol J; 2019 Oct; 7(8):1113-1123. PubMed ID: 31662868
    [Abstract] [Full Text] [Related]

  • 10. Serum cytokeratin-18 and its relation to liver fibrosis and steatosis diagnosed by FibroScan and controlled attenuation parameter in nonalcoholic fatty liver disease and hepatitis C virus patients.
    Darweesh SK, AbdElAziz RA, Abd-ElFatah DS, AbdElazim NA, Fathi SA, Attia D, AbdAllah M.
    Eur J Gastroenterol Hepatol; 2019 May; 31(5):633-641. PubMed ID: 30839434
    [Abstract] [Full Text] [Related]

  • 11. Plasma Cytokeratin-18 Level As a Novel Biomarker for Liver Fibrosis in Children With Nonalcoholic Fatty Liver Disease.
    Mandelia C, Collyer E, Mansoor S, Lopez R, Lappe S, Nobili V, Alkhouri N.
    J Pediatr Gastroenterol Nutr; 2016 Aug; 63(2):181-7. PubMed ID: 26835904
    [Abstract] [Full Text] [Related]

  • 12. Development and validation of a novel non-invasive test for diagnosing fibrotic non-alcoholic steatohepatitis in patients with biopsy-proven non-alcoholic fatty liver disease.
    Gao F, Huang JF, Zheng KI, Pan XY, Ma HL, Liu WY, Byrne CD, Targher G, Li YY, Chen YP, Chan WK, Zheng MH.
    J Gastroenterol Hepatol; 2020 Oct; 35(10):1804-1812. PubMed ID: 32246876
    [Abstract] [Full Text] [Related]

  • 13. Non-Invasive Detection of Fibrotic NASH in NAFLD Patients with Low or Intermediate FIB-4.
    John K, Franck M, Al Aoua S, Rau M, Huber Y, Schattenberg JM, Geier A, Bahr MJ, Wedemeyer H, Schulze-Osthoff K, Bantel H.
    J Clin Med; 2022 Jul 28; 11(15):. PubMed ID: 35956017
    [Abstract] [Full Text] [Related]

  • 14. A novel 2-step approach combining the NAFLD fibrosis score and liver stiffness measurement for predicting advanced fibrosis.
    Chan WK, Nik Mustapha NR, Mahadeva S.
    Hepatol Int; 2015 Oct 28; 9(4):594-602. PubMed ID: 25788185
    [Abstract] [Full Text] [Related]

  • 15. Limited utility of plasma M30 in discriminating non-alcoholic steatohepatitis from steatosis--a comparison with routine biochemical markers.
    Chan WK, Sthaneshwar P, Nik Mustapha NR, Mahadeva S.
    PLoS One; 2014 Oct 28; 9(9):e105903. PubMed ID: 25184298
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Accuracy of cytokeratin 18 (M30 and M65) in detecting non-alcoholic steatohepatitis and fibrosis: A systematic review and meta-analysis.
    Lee J, Vali Y, Boursier J, Duffin K, Verheij J, Brosnan MJ, Zwinderman K, Anstee QM, Bossuyt PM, Zafarmand MH.
    PLoS One; 2020 Oct 28; 15(9):e0238717. PubMed ID: 32915852
    [Abstract] [Full Text] [Related]

  • 19. Noninvasive Assessment of Liver Disease in Patients With Nonalcoholic Fatty Liver Disease.
    Castera L, Friedrich-Rust M, Loomba R.
    Gastroenterology; 2019 Apr 28; 156(5):1264-1281.e4. PubMed ID: 30660725
    [Abstract] [Full Text] [Related]

  • 20. Identifying Nonalcoholic Fatty Liver Disease Advanced Fibrosis in the Veterans Health Administration.
    Patel YA, Gifford EJ, Glass LM, Turner MJ, Han B, Moylan CA, Choi S, Suzuki A, Provenzale D, Hunt CM.
    Dig Dis Sci; 2018 Sep 28; 63(9):2259-2266. PubMed ID: 29779083
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.